Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in MCI and Early Alzheimer's Disease
NCT01965756Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Jan 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in Alzheimer's disease (AD), sponsored by University of Pennsylvania. Started Jan 2013; status: completed.
02
Drugs
metformin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01965756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01965756.